Norry Elliot — SEC Form 4 filings
SEC reporting owner CIK 1798117. 6 Form 4 filings on record with FilingPulse; latest filed 2025-02-20.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-12 to 2025-02-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 4 filings — 60,150 shares, $40,285 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 12,967 shares @ $0.67 ($8,727) in Adaptimmune Therapeutics PLC, filed 2024-01-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC (ADAP) | Chief Medical Officer | 6 | — | 9 legs · 60,150 sh · $40,285 | 4 |
Form 4 filings — Norry Elliot
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-20 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Grant/award (A): 1,612,032 (derivative) @ $0 · Grant/award (A): 1,074,696 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Sale (S): 5,584 @ $0.58 | EDGAR |
| 2025-01-15 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Sale (S): 4,268 @ $0.59 · Sale (S): 8,124 @ $0.59 · Sale (S): 9,803 @ $0.57 | EDGAR |
| 2024-01-17 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Grant/award (A): 2,544,432 (derivative) @ $0 · Grant/award (A): 565,416 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Sale (S): 2,287 @ $0.79 · Sale (S): 5,309 @ $0.67 · Sale (S): 12,967 @ $0.67 | EDGAR |
| 2024-01-12 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Sale (S): 4,009 @ $0.84 · Sale (S): 7,799 @ $0.85 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1798117 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →